Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Business and Professional Services
Investigation Claims on Atara Biotherapeutics, Inc. by Pomerantz LLP New York, NY / ACCESS Newswire / January 24, 2025 Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ:ATRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. Atara Biotherapeutics, Inc. is currently…